Relationship between the oestradiol/oocyte ratio and the outcome of assisted reproductive technology cycles with gonadotropin releasing hormone agonist

Gynecological Endocrinology

Volumn 27, Issue 8, 2011, Pages 558-561

  Var, Turgut ^a   Tonguc, Esra ^a   Dogan, Muammer ^a   Mollamahmutoglu, Leyla ^a  

^a ZEKAI TAHIR BURAK WOMEN S HEALTH EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

E2 follicle ratio; E2 oocyte ratio; gonadotropin releasing hormone agonist; in vitro fertilisation outcome; pregnancy

Indexed keywords

CHORIONIC GONADOTROPIN; DESOGESTREL; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; LEUPRORELIN; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CELL COUNT; DRUG DOSE REDUCTION; ENDOCRINE FUNCTION; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; HUMAN; MENSTRUAL CYCLE; OOCYTE; OVARY CYCLE; OVARY FUNCTION; OVARY HYPERSTIMULATION; PREGNANCY RATE; PREIMPLANTATION EMBRYO; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ALGORITHMS; CHORIONIC GONADOTROPIN; EMBRYO TRANSFER; ESTRADIOL; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY; LEUPROLIDE; MEDICAL RECORDS; OOCYTES; OOGENESIS; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; REPRODUCTIVE TECHNIQUES, ASSISTED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79959991720     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2010.501887     Document Type: Article

References (19)

1. Ghosh D, Sengupta J. Another look at the issue of periimplantation oestrogen. Hum Reprod 1995;10:1-2.
2. Edgar DH. Oestrogen and human implantation. Hum Reprod 1995;10:2-4.
3. De Zeigler D. Hormonal control of endometrial receptivity. Hum Reprod 1995;10:4-7.
4. Simon C, Cano F, Valbuena D, Remohi J, Pellicer A. Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients. Hum Reprod 1995;9:2432-2437.
5. Chenette PE, Sauer MV, Paulson RJ. Very high estradiol levels are not detrimental to clinical outcome of in vitro fertilization. Fertil Steril 1990;54:858-863.
6. Paulson RJ, Sauer MV, Lobo RA. Embryo implantation after human in vitro fertilization: importance of endometrial reseptivity. Fertil Steril 1990;53:870-874. (Pubitemid 20180478)
7. Loumaye E, Engrand P, Howles CM, O'Dea L. Assesment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome. Fertil Steril 1997;67:889-899. (Pubitemid 27195030)
8. Yang J-H, Chen H-F, Lien Y-R, Chen S-U, Ho H-N, Yang Y-S. Elevated E2/oocyte ratio in women undergoing IVF and tubal ET. J Reprod Med 2001;46:434-438.
9. Orvieto R, Zohav E, Scharf S, Rabinson J, Meltcer S, Anteby E, Homburg R. The influence of estradiol/ oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization. Gynecol Endocrinol 2007;23:72-75. (Pubitemid 46481016)
10. Cummins JM, Bren TM, Harrison KL, Shaw JM,Wilson LM, Hennessey JF. A formula for scoring human embryo growth rates in in vitro fertilization: its value in predicting pregnancy and in comparision with visual estimates of embryo quality. J In Vitro Fert Embryo Transf 1986;3:284-295. (Pubitemid 17208120)
11. Ng EHY, Yeung WSB, Lau EYL, So WWK, Ho PC. High serum oestradiol concentrations in fresh IVF cycles do not impair implantation and pregnancy rates in subsequent frozen-thawed embryo transfer cycles. Hum Reprod 2000; 15:250-255. (Pubitemid 30076702)
12. Sharara FI, McClamrock HD. High estradiol levels and high oocyte yield are not detrimental to in vitro fertilization outcome. Fertil Steril 1999;72:401-405. (Pubitemid 29414876)
13. Chen Q-J, Sun X-X, Li L, Gao X-H, Wu Y, Gemzell- Danielsson K, Cheng L-N. Effects of ovarian high response on implantation and pregnancy outcome during controlled ovarian hyperstimulation(with GnRH agonist and rFSH). Acta Obstet Gynecol 2007;86:849-854. (Pubitemid 47035824)
14. Kosmas IP, Kolibianakis EM, Devroey P. Association of estradiol levels on the day of HCG administration and pregnancy achievement in IVF: a systemativ review. Hum Reprod 2004;19:2446-2453. (Pubitemid 39481265)
15. Andersen AN, Devroey P, Arce J-C. Clinical outcome following stimulation with highly purified Hmg or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod 2006;21:3217-3227. (Pubitemid 44811626)
16. Filicori M, Cognigni GE, Gamberini E, Parmegiani L, Troilo E, Roset B. Efficacy of low-dose human chorionic gonadtropin alone to complete controlled ovarian stimulation. Fertil Steril 2005;84:394-401. (Pubitemid 41125260)
17. Dimitry ES, Oskarsson T, Conanghan J, Margara R, Winston RML. Beneficial effects of a 24 h delay in human chorionic gonadotropin administration during in-vitro fertilization. Hum Reprod 1991;6:944-946.
18. Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant folliclestimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril 2004;82:102-107. (Pubitemid 38968785)
19. Kolibianakis EM, Bourgain C, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Prolongation of the follicular phase by delaying HCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles. Hum Reprod 2005;20:2453-2456. (Pubitemid 41222492)